Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial

被引：0
作者：
Jan J. De Waele
S. Carrette
M. Carlier
V. Stove
J. Boelens
G. Claeys
I. Leroux-Roels
E. Hoste
P. Depuydt
J. Decruyenaere
A. G. Verstraete
机构：
[1] Ghent University Hospital,Department of Critical Care Medicine
[2] Ghent University Hospital,Department of Clinical Chemistry, Microbiology and Immunology
来源：
Intensive Care Medicine | 2014年 / 40卷
关键词：
β-Lactam antibiotics; Pharmacokinetics; Pharmacodynamics; Therapeutic drug monitoring; Critical care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：380 / 387
页数：7
相关论文
共 50 条
  • [41] Development and Validation of a Quantitative Determination Method for Meropenem in Blood Plasma for Therapeutic Drug Monitoring
    Kazanova, A. M.
    Stepanova, E. S.
    Makarenkova, L. M.
    Chistyakov, V. V.
    Zyryanov, S. K.
    Senchenko, S. P.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2020, 54 (04) : 414 - 418
  • [42] Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring
    Zhao, Wei
    Lopez, Emmanuel
    Biran, Valerie
    Durrmeyer, Xavier
    Fakhoury, May
    Jacqz-Aigrain, Evelyne
    ARCHIVES OF DISEASE IN CHILDHOOD, 2013, 98 (06) : 449 - 453
  • [43] Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid
    van den Elsen, Simone H. J.
    Akkerman, Onno W.
    Wessels, Mireille
    Jongedijk, Erwin M.
    Ghimire, Samiksha
    van der Werf, Tjip S.
    Bolhuis, Mathieu S.
    Touw, Daan J.
    Alffenaar, Jan-Willem C.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (04)
  • [44] Evidence-based Therapeutic Drug Monitoring for Saquinavir
    Muret, Patrice
    Solas, Caroline
    THERAPIE, 2011, 66 (03): : 207 - 212
  • [45] Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring
    Sparshatt, A.
    Taylor, D.
    Patel, M. X.
    Kapur, S.
    ACTA PSYCHIATRICA SCANDINAVICA, 2009, 120 (06) : 416 - 428
  • [46] Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patients
    Lempers, Vincent J.
    Meuwese, Edme
    Mavinkurve-Groothuis, Annelies M.
    Henriet, Stefanie
    van der Sluis, Inge M.
    Hanff, Lidwien M.
    Warris, Adilia
    Koch, Birgit C. P.
    Bruggemann, Roger J.
    MEDICAL MYCOLOGY, 2019, 57 (08) : 937 - 943
  • [47] Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin
    Karvaly, Gellert Balazs
    Vincze, Istvan
    Neely, Michael Noel
    Zatroch, Istvan
    Nagy, Zsuzsanna
    Kocsis, Ibolya
    Kopitko, Csaba
    PHARMACEUTICS, 2024, 16 (03)
  • [48] The effect of combining therapeutic drug monitoring of antihypertensive drugs with personalised feedback on adherence and resistant hypertension: the (RHYME-RCT) trial protocol of a multi-centre randomised controlled trial
    Peeters, L. E. J.
    Kappers, M. H. W.
    Boersma, E.
    Massey, E. K.
    van Dijk, L.
    van Gelder, T.
    Koch, B. C. P.
    Versmissen, J.
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [49] The effect of combining therapeutic drug monitoring of antihypertensive drugs with personalised feedback on adherence and resistant hypertension: the (RHYME-RCT) trial protocol of a multi-centre randomised controlled trial
    L. E. J. Peeters
    M. H. W. Kappers
    E. Boersma
    E. K. Massey
    L. van Dijk
    T. van Gelder
    B. C. P. Koch
    J. Versmissen
    BMC Cardiovascular Disorders, 23
  • [50] Electrochemical Aptamer-Based Sensors for Improved Therapeutic Drug Monitoring and High-Precision, Feedback-Controlled Drug Delivery
    Dauphin-Ducharme, Philippe
    Yang, Kyungae
    Arroyo-Curras, Netzahualcoyotl
    Ploense, Kyle L.
    Zhang, Yameng
    Gerson, Julian
    Kurnik, Martin
    Kippin, Tod E.
    Stojanovic, Milan N.
    Plaxco, Kevin W.
    ACS SENSORS, 2019, 4 (10) : 2832 - 2837
12345